GMR Solutions Inc. (GMRS) Stock Price & Analysis
GMR Solutions Inc. (GMRS) closed at USD 11.27 on Monday, November 9, 2026, down 9.41% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 12.44; the Nov 9, 2026 session ranged USD 11.04–11.99 on volume of 3,022,648 shares. Market capitalization is $608.82M, with a 52-week range of USD 9–15.98 (NYQ). Source: Nexqual, retrieved November 10, 2026 at 11:20 UTC.
What changed for GMRS since Aug 31, 2025
The built-in knowledge of several widely used AI models ends around Aug 31, 2025. Everything below is newer, dated and sourced (as of Nov 9, 2026).
- Analyst actions on GMRS in the last 120 days: 1 (1 upgrades or target raises, 0 downgrades or target cuts); most recent JP Morgan, Sep 11, 2026.
Also available as compact Markdown for AI agents: nexqual.com/GMRS.md
Latest Earnings Results (GMRS)
GMR Solutions Inc. (GMRS) reported Q3 2026 results on Nov 9, 2026, 4:52:15 PM ET: GAAP EPS $0.56 vs. estimate $0.52 (beat), revenue $1.60B vs. estimate $1.59B (beat). Guidance: GMR updated its full year 2026 guidance for net revenue to a range of $5,900 million to $6,050 million and Adjusted EBITDA to $1,135 million to $1,195 million. Source: SEC 8-K filing. Nexqual published it 36 seconds after release. Read the SEC filing. Full report with estimates: nexqual.com/earnings/2026-11-09/GMRS.
| Fiscal period | EPS (reported) | Revenue | Released | Source |
|---|---|---|---|---|
| Q3 2026 | $0.56 (GAAP diluted) | $1.60B | Nov 9, 2026, 4:52:15 PM ET · on Nexqual +36 seconds | SEC 8-K filing |
Reported actuals captured by Nexqual from SEC 8-K filings and company press releases; each figure confirmed by two independent extraction methods.
Key facts (GMRS)
- Valuation: P/E 3.1x, EV/EBITDA 4.6x, net debt $3.93B.
- Insider open-market sales, last ~7 months: 6 Form 4 filings, $28.7M; 6 not under a Rule 10b5-1 plan ($28.7M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 1.88 on a 1–5 scale) (8 analysts), mean target USD 18.63 (range 14–30).
- Total return with dividends: 1Y -19.4% vs S&P 500 +11.7%; 5Y -15.7% vs S&P 500 +72.2%.
- Latest earnings report: 2026-11-09 (next date not yet announced).
- Dividend: GMRS paid no cash dividend in the last five years.
- Short interest: 4,496,333 shares (as of 2026-10-15), 3.5 days to cover.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (GMRS)
P/E 3.1x · P/S 0.1x · EV/EBITDA 4.6x · EV/Sales 0.8x · P/FCF 3.3x · P/B 0.8x · FCF yield 30.62% · Earnings yield 32.33% · Net debt $3.93B · EV $4.54B
Insider sales (SEC Form 4, open-market, last ~7 months) (GMRS)
0 of 6 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | Van Horne Edward | President & COO | 262,278 | $3.2M | 31.3% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-09-14 | Tierney Brian Scott | EVP & CFO | 265,794 | $3.2M | 32.4% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-09-14 | Loporcaro Nicola | Chairman & CEO | 1,457,102 | $17.8M | 33.8% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-09-14 | Jacoba Lisa | EVP & CHRO | 92,680 | $1.1M | 31.8% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-09-14 | Hall Jessica | Chief Accounting Officer | 23,687 | $289K | 27.5% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-09-14 | Cook Thomas A A | EVP, GC & Secretary | 251,882 | $3.1M | 27.2% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (GMRS)
Consensus Buy (mean 1.88 on a 1–5 scale), 8 analysts; mean target USD 18.63 (low 14, high 30).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-11 | JP Morgan | Target raised | Overweight | $15 → $16 |
Total return (dividends reinvested) (GMRS)
| 1Y (from 2026-05-13) | 5Y (from 2026-05-11) | |
|---|---|---|
| Total return | -19.4% | -15.7% |
| S&P 500 (SPY) | +11.7% | +72.2% |
| Per year | — | — |
| Volatility (annualized) | 64.3% | 64.9% |
| Max drawdown | -40.1% (Jul 2026→Oct 2026) | -36.1% (Jul 2026→Sep 2026) |
Dividends (GMRS)
GMRS paid no cash dividend in the last five years.
Short interest (GMRS)
4,496,333 shares sold short, as of Oct 15, 2026 (exchange short-interest report, published about twice a month). Prior report (Sep 15, 2026): 2,528,187 shares (+77.8%). Days to cover: 3.5 (short shares ÷ average daily volume).
GMRS earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| — | Quarter ended Sep 30, 2026 | $0.64 | $0.54 | Beat +18.5% | — |
| — | Quarter ended Jun 30, 2026 | −$1.56 | $0.32 | Miss −$1.88 | — |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).
GMRS recent SEC filings (last 120 days)
| Filed | Form | What it says |
|---|---|---|
| Nov 9, 2026 | 10-Q | Quarterly report · period ended Sep 30, 2026 |
| Nov 9, 2026 | 8-K | Quarterly results |
| Nov 5, 2026 | Schedule 13G/A | FMR LLC, Abigail P. Johnson: 3.4% of shares, passive 5%+ holder (amended) |
| Sep 17, 2026 | 8-K | Entered a material agreement; New debt or off-balance-sheet obligation; Other material event “On September 17, 2026, GMR Intermediate Corp. and Global Medical Response, Inc. ("GMR, Inc."), each a subsidiary of GMR Solutions Inc. (the "Company"), entered into Amendment No. 1 (the "Amendment") to the credit agreement governing GMR, Inc.'s existing first lien term loan facility. Pursuant to the Amendment, all of GMR, Inc.'s existing first lien term loans after giving effect to the repayment below were refinanced through a replacement term loan facility as part of a repricing transaction. The applicable…” |
| Sep 11, 2026 | 8-K | Other material event “On September 11, 2026, Global Medical Response, Inc. ("GMR, Inc."), a subsidiary of GMR Solutions Inc. (the "Company"), announced it has received binding commitments from lenders sufficient to complete a repricing transaction with respect to GMR, Inc.'s existing first lien term loan facility. A copy of the press release is attached hereto as Exhibit 99.1 and is hereby incorporated by reference. The repricing transaction is expected to amend GMR, Inc.'s existing first lien term loan. In connection with the…” |
| Aug 20, 2026 | Schedule 13G | North Peak Capital Management, LLC, North Peak Capital GP, LLC: 6.2% of shares, passive 5%+ holder |
| Aug 14, 2026 | Schedule 13G | Pegasus Aggregator Holdco LLC, Pegasus Aggregator Parent LLC: 81.1% of shares, passive 5%+ holder |
| Aug 13, 2026 | Schedule 13G | Invesco Ltd.: 5.7% of shares, passive 5%+ holder |
| Aug 12, 2026 | 10-Q | Quarterly report · period ended Jun 30, 2026 |
| Aug 12, 2026 | 8-K | Quarterly results |
| Aug 12, 2026 | Schedule 13G | Norges Bank: 5.5% of shares, passive 5%+ holder |
| Aug 6, 2026 | Schedule 13G | FMR LLC, Abigail P. Johnson: 6.2% of shares, passive 5%+ holder |
Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.
GMRS revenue by product line (quarter ended Sep 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Health Care Patient Service | $1.54B | 96.4% | +5.6% |
| — Commercial Insurance & Managed Care Excluding Medicare & Medicaid Managed Care (part of Health Care Patient Service) | $883.2M | 55.4% | +1.1% |
| — Medicare (part of Health Care Patient Service) | $380.6M | 23.9% | +14.6% |
| — Medicaid (part of Health Care Patient Service) | $132.4M | 8.3% | +16.1% |
| — Other Third Party Payors (part of Health Care Patient Service) | $124.8M | 7.8% | +9.7% |
| — Self Payment (part of Health Care Patient Service) | $16.9M | 1.1% | -28.9% |
| Complementary Revenue | $57.7M | 3.6% | +15.5% |
| Total revenue | $1.60B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
GMRS analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $0.21 | $0.23 | -6.8% | $1.49B | 7 |
| Next quarter (ends Mar 2027) | $0.39 | $0.38 | +2.7% | $1.53B | 5 |
| Current fiscal year (ends Dec 2026) | $1.87 | $1.62 | +15.3% | $6.03B | 7 |
| Next fiscal year (ends Dec 2027) | $1.83 | $1.80 | +1.4% | $6.36B | 7 |
Key Statistics (as of November 10, 2026 at 11:20 UTC)
| Price | USD 11.27 |
|---|---|
| Change | ▼ 9.41% (down) |
| Previous Close | USD 12.44 |
| Open | USD 11.35 |
| Day Range | USD 11.04 – 11.99 |
| 52-Week Range | USD 9 – 15.98 |
| Volume | 3,022,648 shares |
| Market Cap | $608.82M |
| Exchange | NYQ |
Technical Analysis (GMRS)
Nexqual's technical model rates GMRS "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of November 10, 2026 at 11:20 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.77 (neutral) |
| vs SMA50 | Below (USD 11.35) |
| MACD | 0.26 (positive) |
Analyst Ratings (GMRS)
Wall Street analysts rate GMRS "Buy" based on 8 analysts, with a mean price target of USD 18.63 (range USD 14–30), per Nexqual as of November 10, 2026 at 11:20 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 8 |
| Mean Target | USD 18.63 |
| High Target | USD 30 |
| Low Target | USD 14 |
| Buy / Hold / Sell | 7 / 1 / 0 |
Earnings (GMRS)
| Next Earnings Date | 2026-11-09 |
|---|---|
| EPS Estimate | USD 0.21 |
| Revenue Estimate | $1.49B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 0.64 vs est 0.54 ▲ beat |
| 2026-06-30 | USD -1.56 vs est 0.32 ▼ miss |
Source: Nexqual, November 10, 2026 at 11:20 UTC.
Financials & Fundamentals (GMRS)
| Total Revenue | $5.97B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +5.90% |
| Gross Margin | +36.10% |
| Operating Margin | +16.39% |
| Profit Margin | +3.79% |
| Debt / Equity | 5.07 |
| Current Ratio | 1.75 |
| Total Cash | $297.99M |
| Total Debt | $4.60B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $186.41M (3.2% of revenue) |
Source: Nexqual, November 10, 2026 at 11:20 UTC.
Financial Health Score (GMRS)
Nexqual rates GMR Solutions Inc.'s overall financial health "Mixed" across five dimensions, as of November 10, 2026 at 11:20 UTC.
| Growth | Solid — Revenue +6% YoY (latest Q) |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Critical — $490M cash and investments vs $4.42B debt (Jun 2026, SEC) |
| Cash Flow | Mixed — FCF $186M (last 4 quarters to Jun 2026, SEC), slim 3.2% margin |
| Efficiency | Strong — ROE 25%, ROA 2.6% (last 4 quarters, SEC) |
Ownership (GMRS)
| Insider Ownership | +8.01% |
|---|---|
| Institutional Ownership | +100.18% |
| Shares Outstanding | 54.02M |
| Float | 29.50M |
Source: Nexqual, November 10, 2026 at 11:20 UTC.
Leadership (GMRS)
GMR Solutions Inc. is led by Nicola Loporcaro Eng., CEO & Chairman of the Board, per Nexqual as of November 10, 2026 at 11:20 UTC.
| CEO & Chairman of the Board | Nicola Loporcaro Eng. |
|---|---|
| COO & President | Edward Van Horne |
| Executive VP & CFO | Brian Scott Tierney |
| Vice President of Investor Relations | Krister Sorensen |
| Associate Vice President of Public Relations | Kirsten Gurmendi |
Major Backers & Investors (GMRS)
Notable institutional backers of GMR Solutions Inc. include Kohlberg Kravis Roberts & Co. L.P., FMR, LLC, Citadel, according to Nexqual as of November 10, 2026 at 11:20 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | 27.37% |
| FMR, LLC | 6.22% |
| Citadel | 5.9% |
| Invesco | 5.72% |
| NORGES BANK | 5.46% |
| Healthcare of Ontario Pension Plan Trust Fund | 4.44% |
| Alyeska Investment Group, L.p. | 4.41% |
| Koch, Inc. | 4.08% |
Source: Nexqual, November 10, 2026 at 11:20 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CMPS | COMPASS Pathways Plc - American | USD 9.18 | ▲ 6.62% |
| INNV | InnovAge Holding Corp. | USD 9.21 | ▲ 2.68% |
| NUTX | Nutex Health Inc. | USD 194.16 | ▲ 7.53% |
| PNTG | The Pennant Group, Inc. | USD 36.26 | ▼ 0.28% |
| AMN | AMN Healthcare Services Inc | USD 37.71 | ▲ 4.2% |
| USPH | U.S. Physical Therapy, Inc. | USD 99.84 | ▲ 0.35% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: November 10, 2026 at 11:20 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt